CAU
LLY icon

Caxton Associates (UK)’s Eli Lilly LLY Stock Holding History

Caxton Associates (UK)’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.4M Buy
1,526
+1,120
+276% +$1.14M 0.03% 300
2025
Q4 		$436K Sell
406
-894
-69% -$855K 0.01% 536
2025
Q3 		$992K Buy
+1,300
New +$967K 0.02% 341
2025
Q2 		– Sell
-2,570
Closed -$2.12M – 808
2025
Q1 		$2.12M Buy
+2,570
New +$2.14M 0.07% 145

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Caxton Associates (UK)'s LLY Position: Q1 2026 in Review

Caxton Associates (UK) increased its Eli Lilly (LLY) stake by 276% in Q1 2026, buying an estimated $1.14M and bringing the position to 1,526 shares worth $1.4M. The position accounts for 0.03% of the portfolio, ranked #300.

Caxton Associates (UK) first reported a position in LLY in Q1 2025 and has held it in 4 quarters since. The position peaked at $2.12M in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Caxton Associates (UK) held 1,526 shares of Eli Lilly worth $1.4M as of Q1 2026.
  • Caxton Associates (UK) bought 1,120 Eli Lilly shares in Q1 2026, an estimated $1.14M.
  • Eli Lilly made up 0.03% of Caxton Associates (UK)'s portfolio in Q1 2026, its #300 holding.
  • Caxton Associates (UK) first reported a position in Eli Lilly in Q1 2025 and has held it in 4 quarters since.
  • Caxton Associates (UK)'s Eli Lilly position peaked at $2.12M in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.